IP Library Granted Patent US 9,115,389
Granted Patent B2
US 9,115,389 · App. 12/308,954 · Granted Aug 25, 2015

Method for detecting a target nucleic acid comprising two portions using probes having a first portion complementary to the first portion of the target nucleic acid and a second portion substantially complementary to the second portion of the target nucleic acid

Inventors: Shlomit Gilad (Ganei Hadar, IL); Esther Meiri (Shoham, IL)
Assignee: Rosetta Genomics Ltd.
C12Q1/6816C12Q1/6832C12Q1/6853C12Q1/6886C12Q2600/136C12Q2600/178
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,115,389
App. No.
12/308,954
Granted
Aug 25, 2015
Kind
B2
Abstract

Described herein are methods and compositions for detecting, amplifying and labeling targeted nucleic acids, including microRNAs.

Claims (19)

1. A method of specifically detecting, identifying and quantifying a plurality of microRNAs in a biological sample obtained from a subject, wherein said plurality of microRNAs differ from each other by at least one nucleotide, said method comprising:

(a) providing RNA from said sample, wherein said RNA comprises microRNAs;

(b) polyadenylating the RNA;

(c) generating a reverse transcript of the polyadenylated RNA using a linear reverse transcript primer, wherein said primer is not complementary to the microRNAs; and

(d) amplifying the reverse transcript of step (c) and specifically quantifying the plurality of microRNAs by polymerase chain reaction comprising a forward primer, a reverse primer, and a linear probe.

2. The method of claim 1 , wherein the biological sample is selected from the group consisting of: biopsy, tissue sample, blood, serum, urine, amniotic fluid, ascitic fluid, saliva, cervical secretions, vaginal secretions, effusions, endometrial secretions, gastrointestinal secretions, bronchial secretions, sputum, pleural effusion, secretions from the breast, secretions from ovarian cyst, and sperm.

3. The method of claim 1 , wherein said probe further comprises a minor groove binder.

4. The method of claim 1 , wherein the forward primer comprises a sequence selected from the group consisting of any one of SEQ ID NOS: 4168-8334.

5. The method of claim 1 , wherein the probe comprises a sequence selected from the group consisting of any one of SEQ ID NOS: 8335-20835.

6. A method of detecting a target RNA nucleic acid in a biological sample, wherein said target RNA nucleic acid sequence is a microRNA or an siRNA, the method comprising:

(a) providing the biological sample comprising the target RNA nucleic acid sequence;

(b) annealing the target RNA nucleic acid sequence with a poly(T) primer comprising a 5′ universal adaptor sequence;

(c) generating a reverse transcript of the polyadenylated RNA with the poly(T) primer of step (b); and

(d) amplifying the reverse transcript of step (c) by a polymerase chain reaction (PCR) comprising a specific forward primer, a universal reverse primer and a specific probe, to generate an amplicon;

wherein the forward primer is at least partially identical to the target RNA nucleic acid sequence, the universal reverse primer is at least partially identical to a 5′ region of the adaptor sequence of the poly (T) primer and the specific probe comprises at least one mismatch at the 3′ end of the constant region of the amplicon.

7. The method of claim 6 , wherein said target RNA sequence of step (a) is extended at the 3′ end by polyadenylation prior to step (b).

8. The method of claim 1 , wherein the probe comprises a label.

9. The method of claim 8 , wherein the label comprises a fluorophore.

10. The method of claim 9 , wherein the label further comprises a quencher molecule, and wherein the fluorophore is located on the probe distal to the quencher molecule.

Assignments (2)
SECURITY INTEREST Recorded Dec 15, 2017
From: ROSETTA GENOMICS INC.; ROSETTA GENOMICS LTD; MINUET DIAGNOSTICS, INC.; CYNOGEN INC.
To: GENOPTIX, INC.
Reel/Frame 044899/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2009
From: SHLOMIT, GILAD; MEIRI, ESTHER; YERUSHALMI, NOGA
To: ROSETTA GENOMICS LTD.
Reel/Frame 022899/0924 →
Continuity (5)
Provisional Application 60806404 · Jun 30, 2006
Provisional Application 60822371 · Aug 14, 2006
Provisional Application 60850455 · Oct 10, 2006
Provisional Application 60871095 · Dec 20, 2006
Related Publication 20100047784A1 · Feb 25, 2010